Cannabinoid CB1 receptor and gastric acid secretion [3]

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 3102-3103

  Borrelli, Francesca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; PENTAGASTRIN; RIMONABANT;

DRUG MECHANISM; ELECTRIC FIELD; HUMAN; LETTER; OBESITY; PRIORITY JOURNAL; STOMACH ACID SECRETION;

ANIMALS; BENZOXAZINES; BIOLOGICAL MARKERS; CALCIUM CHANNEL BLOCKERS; ENZYME INHIBITORS; GASTRIC ACID; MORPHOLINES; NAPHTHALENES; OUABAIN; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; STOMACH;

EID: 34848883982     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9507-4     Document Type: Letter

References (6)

1. Coutts AA, Izzo AA (2004) The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol 4:572-579
2. Coruzzi G, Adami M, Guaita E, Menozzi A, Bertini S, Giovannini E, Soldani G (2006) Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. Dig Dis Sci 51:310-317
3. +, K(+)-ATPase inhibitor ouabain in mouse isolated stomach. Gen Pharmacol 27:905-909
4. Izzo AA, Mascolo N, Capasso F (2001) The gastrointestinal pharmacology of cannabinoids. Curr Opin Pharmacol 1:597-603
5. Halford JC (2006) Obesity drugs in clinical development. Curr Opin Investig Drugs 7:312-318
6. Padwal R, Majumdar S (2006) Metabolic risk factors, drugs, and obesity. N Engl J Med 354:974-975